Form 8-K - Current report:
SEC Accession No. 0001628280-15-003449
Filing Date
2015-05-01
Accepted
2015-05-01 17:12:29
Documents
1
Period of Report
2015-05-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K a8k-april2015xvoteofannual.htm 8-K 34925
  Complete submission text file 0001628280-15-003449.txt   35967
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 15825460
SIC: 2834 Pharmaceutical Preparations